The Department of Health and Human Services Food and Drug Administration awarded a single award indefinite delivery contract to Iqvia Government Solutions Inc. to provide hospital drug utilization data and regulatory drug utilization services. The base period of performance is from March 2020 through March 2025 with a potential value of $9 million. Under the first delivery order valued at $3.667 million, Iqvia will deliver hospital drug data from Silver Spring, Maryland through April 2025. The...
This Indefinite Delivery Contract (IDC) was awarded by the Food and Drug Administration (FDA) to Iqvia Government Solutions Inc., a prominent for-profit organization specializing in healthcare data, analytics, and clinical research services. The contract has a ceiling value of $16,803,000.00 and a period of performance from August 20, 2025, to August 21, 2027. The purpose of this IDC is to provide the FDA's Center for Drug Evaluation and Research with comprehensive access to outpatient...
This indefinite delivery contract was awarded by the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services, to Iqvia Government Solutions Inc., a prominent healthcare data and analytics provider. The contract, valued at up to $3,169,963.15, provides the FDA with access to over-the-counter (OTC) drug utilization data to strengthen the agency's drug monitoring and safety surveillance programs. Through a series of firm fixed price delivery...
The federal contract IDV award with ID 75F40118D10007 is an Indefinite Delivery Contract (IDC) issued by the Food and Drug Administration (FDA), a civilian agency, to Syneos Health Research & Insights LLC, a for-profit limited liability company. The contract has a ceiling value of $2,947,016.61 and a period of performance running from the award date of May 16, 2018 to the ultimate completion date of May 16, 2023. The contract is for "ACCESS TO HEALTH CARE PRACTITIONER PRESCRIBING...
This Indefinite Delivery Contract (IDC) was awarded by the U.S. Food and Drug Administration (FDA), a civilian federal agency, to Iqvia Government Solutions Inc., a for-profit organization specializing in healthcare data, analytics, and research services. The contract has a ceiling value of $4,463,492.67 and a period of performance extending to July 14, 2030. The primary objective of this contract is to provide the FDA with comprehensive hospital inpatient and emergency department drug...
This Blanket Purchase Agreement awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1 provides first fill emergency prescription services. The single award BPA has a potential value of $3 million over five years from August 2023 to July 2028. R & M Reyes Enterprise, LLC is the prime contractor. The BPA enables 14 VA medical centers, community based outpatient clinics, and mobile medical units across Maine, New Hampshire, Vermont,...
The federal contract IDV award, valued up to $10 million, was issued by the U.S. Food and Drug Administration (FDA) to the Denver Health and Hospital Authority (Denver Health), a U.S. local/state government entity and healthcare provider. The contract provides data resources to support the FDA's post-marketing surveillance of nonmedical use of pharmaceuticals and illicit drug use. Under this IDV, Denver Health has been awarded multiple firm fixed-price delivery orders. These include a $205,010...
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a multiple-award indefinite-delivery indefinite-quantity (IDIQ) contract for the Biologics Effectiveness and Safety (BEST) Initiative #3: Data Sources for Surveillance of Biologics. The prime contractor, The Lewin Group, Inc. (doing business as Lewing Group Inc.), a subsidiary of UnitedHealth Group Incorporated, will provide data sources containing administrative claims data or claims and electronic...
The Pretrial Services Agency awarded a multiple award indefinite delivery contract to La Clinica Del Pueblo, Inc. to provide medically managed substance abuse treatment services. Task orders issued against the contract include $57,563.52 for intensive outpatient treatment from September 2020 through September 2021 in Washington, D.C. The original solicitation sought proposals for residential and outpatient substance abuse and co-occurring behavioral health treatment services levels 2.1 through 4...
The Trustees of the University of Pennsylvania received a single-award indefinite-delivery contract from the Department of Health and Human Services Food and Drug Administration. The contract has a potential value of $2.3M to support a scalable, patient-centered approach to optimizing opioid prescribing practices through September 2023. No set-aside was used in the award. The original solicitation sought research and development to advance regulatory science and innovation in line with the FDA's...